Reduce the risk of metabolic syndrome (MetS) due to reduction of abdominal fat. Lowered postprandial glucose levels and serum postprandial thioredoxin. Increases antioxidant capacity and inhibited protein oxidation in postprandial hyperglycaemia. The gene discussed is TXN; the disease is Hyperglycemia.